Envestnet Asset Management Inc. Sells 150 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Envestnet Asset Management Inc. decreased its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 0.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,595 shares of the medical instruments supplier’s stock after selling 150 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Mesa Laboratories were worth $2,320,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. Resona Asset Management Co. Ltd. acquired a new stake in Mesa Laboratories in the fourth quarter worth $92,000. ExodusPoint Capital Management LP lifted its holdings in Mesa Laboratories by 283.8% during the fourth quarter. ExodusPoint Capital Management LP now owns 9,692 shares of the medical instruments supplier’s stock worth $1,278,000 after acquiring an additional 7,167 shares in the last quarter. Alliancebernstein L.P. grew its stake in Mesa Laboratories by 2.6% in the fourth quarter. Alliancebernstein L.P. now owns 5,584 shares of the medical instruments supplier’s stock valued at $736,000 after acquiring an additional 141 shares during the period. Wellington Management Group LLP bought a new stake in shares of Mesa Laboratories in the fourth quarter worth about $1,888,000. Finally, Vanguard Group Inc. raised its position in shares of Mesa Laboratories by 1.4% during the fourth quarter. Vanguard Group Inc. now owns 382,856 shares of the medical instruments supplier’s stock worth $50,487,000 after purchasing an additional 5,274 shares during the period. Institutional investors and hedge funds own 90.60% of the company’s stock.

Mesa Laboratories Price Performance

Shares of MLAB opened at $116.48 on Friday. The stock has a 50 day simple moving average of $123.78 and a 200 day simple moving average of $127.14. Mesa Laboratories, Inc. has a 52-week low of $83.68 and a 52-week high of $155.12. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.53 and a current ratio of 0.71. The firm has a market capitalization of $632.95 million, a PE ratio of -2.52 and a beta of 0.92.

Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings data on Tuesday, February 4th. The medical instruments supplier reported $2.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 104.92% and a positive return on equity of 30.23%. Sell-side analysts predict that Mesa Laboratories, Inc. will post 8 EPS for the current fiscal year.

Mesa Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Friday, May 30th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 0.55%. The ex-dividend date of this dividend is Friday, May 30th. Mesa Laboratories’s dividend payout ratio is -1.38%.

Insider Activity

In related news, CEO Gary M. Owens sold 21,000 shares of Mesa Laboratories stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $123.91, for a total value of $2,602,110.00. Following the sale, the chief executive officer now owns 43,337 shares of the company’s stock, valued at approximately $5,369,887.67. This trade represents a 32.64 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 4.40% of the company’s stock.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.